PROQR THRAPEUTICS N V SHS EURO

PROQR THRAPEUTICS N V SHS EURO is a security (CUSIP N71542109) tracked across SEC portfolio filings. 69 institutional managers reported $66.8M on Form 13F as of 2026-06-30; 1 registered fund positions totaling $76K via N-PORT as of 2026-05-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 69 managers by value.

ManagerLocationValueShares
Aberdeen Group plcEDINBURGH, X0$16.6M8,932,507
ADAGE CAPITAL PARTNERS GP, L.L.C.Boston, MA$10.1M6,253,467
Privium Fund Management B.V.AMSTERDAM, P7$8.9M5,467,149
Affinity Asset Advisors, LLCNew York, NY$4.0M2,454,278
Sio Capital Management, LLCNew York, NY$3.2M1,954,715
DAFNA Capital Management LLCLOS ANGELES, CA$2.5M1,567,561
Kynam Capital Management, LPPRINCETON, NJ$2.5M1,566,317
Ikarian Capital, LLCDALLAS, TX$2.4M1,492,229
MORGAN STANLEYNEW YORK, NY$2.1M1,299,775
PLATINUM INVESTMENT MANAGEMENT LTDSYDNEY AUSTRALIA 2000, C3$2.0M1,235,514
TWO SIGMA INVESTMENTS, LPNew York, NY$1.5M918,857
Point72 Asset Management, L.P.Stamford, CT$1.2M755,842
CITADEL ADVISORS LLCMIAMI, FL$1.1M703,323
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.PHILADELPHIA, PA$1.0M620,000
M28 Capital Management LPStamford, CT$972K599,793

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Invesco NASDAQ Future Gen 200 ETFInvesco Exchange-Traded Fund Trust II$76K40.39%

More